The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
Metabolism
; 104: 154054, 2020 03.
Article
in En
| MEDLINE
| ID: mdl-31887309
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Linagliptin
/
Hypoglycemic Agents
/
Life Style
/
Metformin
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Metabolism
Year:
2020
Document type:
Article